Previous 10 | Next 10 |
home / stock / shtdf / shtdf news
Sinopharm's revenue and net income grew by +7.3% and +14.9% YoY in FY 2020 which was better than expected, but the company's operating cash flow decreased by -40.6% last year. The recent fourth round of China's centralized drug procurement program has similar negative trends as t...
MRK was developing two candidates in this category - with Themis they were working on a measles-based one, and the IAVI a VSV-based one. But the company announced today that they're dropping both of them after looking at the first human Phase I data. Adverse effects in the US, Israel,...
On Wednesday, China's National Medical Products Administration granted the conditional marketing approval for the COVID-19 vaccine candidate developed by Beijing Biological Products Institute and Sinopharm Group (SHTDF).Based mainly on trials conducted in the United Arab Emirates, t...
The UK authorities have approved Oxford/AstraZeneca’s adenovirus vector vaccine for distribution there. Of special interest is the intent to give as many people as possible a first shot, without holding back supplies for the second round. This is simultaneously the correct decision...
Sinopharm Group's poor share price performance and forward P/E valuation multiple de-rating in the past few years is attributable to policy headwinds. There has been a deterioration in Sinopharm Group's operating cash flow and working capital metrics in 1H 2020, due to the negative im...
Singapore is poised to become Asia's first country to receive Pfizer (PFE), BioNTech's (BNTX) coronavirus vaccine, report.Prime Minister Lee Hsien Loong, in a televised address, said the first doses are due to arrive later in December, and that other vaccines would also be coming in the month...
Bahrain has approved the use of a China's coronavirus vaccine, developed by Sinopharm (SHTDF), following earlier vaccine approval made by Pfizer (PFE) and its German partner BioNTech (BNTX). Bahrain's news agency said the Chinese vaccine would be available in the island kingdom off ...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. DoorDash delivers bumper IPODecember is usually a quiet time for the IPO market, but this year there will instead be a flurry of offerings as the pandemic ...
Vaccine headlines continue to pour following V-Day in the U.K., brighter news on the University of Oxford and AstraZeneca (AZN) jab and the possibility of mandatory vaccinations for New Yorkers.The latest? China's state-backed coronavirus vaccine, developed by Sinopharm (SHTDF), was found to ...
Genetron Health, a Beijing-North Caroline diagnostic company, announced a city-wide early screening test for liver cancer in Wuxi city using the company's blood-based HCCscreen. Sinopharm has filed for China approval of at least one of its two COVID-19 inactivated vaccines based on in...
News, Short Squeeze, Breakout and More Instantly...
Sinopharm Group Co. Ltd. Company Name:
SHTDF Stock Symbol:
OTCMKTS Market:
New York City, NY: May 04, 2020 – Published via (Wired Release):- “Market.us presents a new report titled Ammonium Phosphomolybdate Market: 2020 Research and New Innovations in Oil and Gas Sector. The prime objective of the report is to offer updates and information related to f...